MedTrace Logo

Baromètre Santé Adulte 2021-2022

NCT05218304 · Status: SUSPENDED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 5471

Last updated 2022-02-01

No results posted yet for this study

Summary

In 2021-2022, Agence Sanitaire et Sociale Nouvelle Calédonie (ASSNC) is undertaking the "Baromètre Santé Adulte" for the third time. This study is carried out this year in collaboration with WHO and Institut Pasteur de Nouvelle Calédonie (IPNC).

The main objective of this investigation is to describe the current levels of chronic disease risk factors in the adult population of New Caledonia aged from 18 to 64 years old. This study will also help to estimate prevalence of certain diseases (diabetes, hypercholesterolemia, renal failure), seroprevalence of arboviruses (dengue fever, Zika, chikungunya and Ross River) malaria as well as the seroprevalence of SARS-CoV-2.

Repeated regularly, these surveys allow the ASS-NC to capitalize on population indicators, to compare them according to socio-demographic characteristics, to identify groups at risk, to provide changes in health behaviors and to strengthen analytical capacities in order to adapt the guidelines for public policies and prevention programs.

Conditions

Interventions

BIOLOGICAL

Blood sample

A questionnaire, physical measurements (height, weight, perimeter abdominal and blood pressure) for all arm will be done, approximately 5400 people carried out by investigators. Only 1800 will undergo blood samples carried out by nurses

Sponsors & Collaborators

  • Institut Pasteur

    collaborator INDUSTRY

  • Pacific Community

    collaborator OTHER

  • World Health Organization

    collaborator OTHER

  • Institut de la Statitique et des Etudes Economiques Nouvelle Calédonie

    collaborator UNKNOWN

  • Agence Sanitaire et Sociale de Nouvelle Calédonie

    lead OTHER_GOV

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
64 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-07-26
Primary Completion
2022-04-30
Completion
2022-05-30

Countries

  • New Caledonia

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05218304 on ClinicalTrials.gov